Close Menu

NEW YORK – Spartan Bio said this week that it has tapped Cardinal Health for US distribution of its CYP2C19 genotyping assay for mutations that affect approximately 15 percent of all prescribed drugs. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.